Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
426 Ergebnisse
| JU3576 | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 42,269 % | 0,763 | -0,105 | 4,040 | 18.12.2026 | 0,100 | JP Morgan | ||
| SX5K5A | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 43,004 % | 0,733 | -0,102 | 3,875 | 15.01.2027 | 0,100 | Société Générale | ||
| FD1YTM | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 46,679 % | 0,781 | -0,165 | 5,385 | 18.09.2026 | 0,100 | Société Générale | ||
| FE1AXT | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 44,615 % | 0,723 | -0,092 | 3,385 | 19.03.2027 | 0,100 | Société Générale | ||
| FE1AXN | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 43,245 % | 0,737 | -0,110 | 4,111 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58UX | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 43,242 % | 0,724 | -0,079 | 3,070 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VE | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420,000 | call | Vertex Pharmaceuticals Inc. | - | 42,587 % | 0,729 | -0,061 | 2,576 | 21.01.2028 | 0,100 | Société Générale | ||
| MM215R |  | Vertex Pharmaceuticals Inc./OS/Call [425]/MS | - | - | 425,000 | call | Vertex Pharmaceuticals Inc. | - | 44,324 % | 0,722 | -0,011 | 4,106 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM215S | | Vertex Pharmaceuticals Inc./OS/Call [425]/MS | - | - | 425,000 | call | Vertex Pharmaceuticals Inc. | - | 44,908 % | 0,713 | -0,008 | 3,021 | 17.06.2027 | 0,010 | Morgan Stanley | |
| JU31US | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430,000 | call | Vertex Pharmaceuticals Inc. | - | 42,499 % | 0,757 | -0,160 | 6,051 | 18.09.2026 | 0,100 | JP Morgan | ||
| JU3P36 | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430,000 | call | Vertex Pharmaceuticals Inc. | - | 42,125 % | 0,735 | -0,110 | 4,199 | 18.12.2026 | 0,100 | JP Morgan | ||
| JU3WSY | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430,000 | call | Vertex Pharmaceuticals Inc. | - | 42,404 % | 0,709 | -0,104 | 4,035 | 15.01.2027 | 0,100 | JP Morgan | ||
| GW3ZU6 | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 39,733 % | 0,709 | -0,101 | 4,245 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW4K2D | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 40,009 % | 0,684 | -0,089 | 3,853 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW5B2A | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 39,581 % | 0,687 | -0,077 | 3,422 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| JH5U18 | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 42,470 % | 0,713 | -0,172 | 6,428 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 42,041 % | 0,685 | -0,114 | 4,486 | 18.12.2026 | 0,100 | JP Morgan | ||
| JH9BEQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 43,099 % | 0,701 | -0,108 | 4,011 | 15.01.2027 | 0,100 | JP Morgan | ||
| JE11YQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPMD | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 44,519 % | 0,697 | -0,097 | 3,489 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE84H4 | Vertex Pharmaceuticals Inc./OS/Call [440]/JPMD | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 43,392 % | 0,701 | -0,082 | 3,140 | 17.06.2027 | 0,100 | JP Morgan | ||
| SX5K5B | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 42,276 % | 0,683 | -0,107 | 4,171 | 15.01.2027 | 0,100 | Société Générale | ||
| FE4XZ1 | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 42,301 % | 0,684 | -0,115 | 4,469 | 18.12.2026 | 0,100 | Société Générale | ||
| FE58HC | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 44,580 % | 0,707 | -0,180 | 6,205 | 18.09.2026 | 0,100 | Société Générale | ||
| FE58HG | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 43,178 % | 0,699 | -0,094 | 3,564 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58UY | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 42,326 % | 0,687 | -0,080 | 3,253 | 17.06.2027 | 0,100 | Société Générale | ||
| FE58VF | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 41,869 % | 0,697 | -0,062 | 2,698 | 21.01.2028 | 0,100 | Société Générale | ||
| VH625J | | Vertex Pharmaceuticals Inc./OS/Call [440]/VONT | - | - | 440,000 | call | Vertex Pharmaceuticals Inc. | - | 41,274 % | 0,682 | -0,105 | 4,258 | 15.01.2027 | 0,100 | Vontobel | |
| GV94RT | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 39,493 % | 0,675 | -0,169 | 7,189 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GV9CUW | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 37,859 % | 0,687 | -0,107 | 4,872 | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GV9LTG | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 39,237 % | 0,659 | -0,103 | 4,559 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GU1HKH | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 39,155 % | 0,668 | -0,077 | 3,522 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW319W | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 39,975 % | 0,659 | -0,090 | 3,965 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW319Y | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,654 % | 0,683 | -0,063 | 2,749 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GN07QL | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 37,456 % | 0,668 | -0,136 | 6,386 | 16.10.2026 | 0,100 | Goldman Sachs | ||
| JH5U1M | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,902 % | 0,667 | -0,179 | 6,886 | 18.09.2026 | 0,100 | JP Morgan | ||
| JH5SJR | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,245 % | 0,654 | -0,115 | 4,721 | 18.12.2026 | 0,100 | JP Morgan | ||
| JH9BER | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 42,399 % | 0,652 | -0,109 | 4,309 | 15.01.2027 | 0,100 | JP Morgan | ||
| MJ860U | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,751 % | 0,654 | -0,012 | 4,677 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KUZ | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 43,248 % | 0,665 | -0,008 | 3,278 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5JNY | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 46,368 % | 0,659 | -0,020 | 6,360 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN04AE | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 46,304 % | 0,681 | -0,007 | 2,617 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6FTA | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 44,032 % | 0,657 | -0,010 | 3,683 | 19.03.2027 | 0,010 | Morgan Stanley | |
| SX5KSM | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 43,613 % | 0,660 | -0,186 | 6,703 | 18.09.2026 | 0,100 | Société Générale | ||
| FA53J9 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,669 % | 0,652 | -0,116 | 4,692 | 18.12.2026 | 0,100 | Société Générale | ||
| FD1ZF7 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 43,074 % | 0,656 | -0,096 | 3,752 | 19.03.2027 | 0,100 | Société Générale | ||
| FE58U5 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 42,116 % | 0,670 | -0,071 | 3,035 | 17.09.2027 | 0,100 | Société Générale | ||
| FE58U9 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,953 % | 0,678 | -0,065 | 2,813 | 17.12.2027 | 0,100 | Société Générale | ||
| VJ5DDE | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 39,023 % | 0,684 | -0,110 | 4,765 | 18.12.2026 | 0,100 | Vontobel | |
| VY41Y4 | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 44,552 % | 0,666 | -0,085 | 3,201 | 17.06.2027 | 0,100 | Vontobel | |
| VY5LM5 | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450,000 | call | Vertex Pharmaceuticals Inc. | - | 41,646 % | 0,664 | -0,178 | 6,955 | 18.09.2026 | 0,100 | Vontobel |